| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/18/2002 | CA2431566A1 Topical testosterone formulations and associated methods |
| 07/18/2002 | CA2431543A1 Method of producing porous tablets with improved dissolution properties |
| 07/18/2002 | CA2431236A1 Therapeutic film forming composition and treatment system |
| 07/18/2002 | CA2428075A1 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | CA2403617A1 Agent for prevention or treatment of allergosis, and medical aqueous agent, ophthalmic solution and nasal drop for allergosis |
| 07/17/2002 | EP1222932A1 Compositions for electroporation |
| 07/17/2002 | EP1222931A1 Percutaneous absorption promoters for electroporation |
| 07/17/2002 | EP1222930A1 Compositions for electroporation |
| 07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
| 07/17/2002 | EP1222923A1 Nicotine transdermal delivery composition for smoking cessation |
| 07/17/2002 | EP1222922A1 Method for stabilizing benzimidazole compounds |
| 07/17/2002 | EP1222918A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 07/17/2002 | EP1222917A1 Compression molded product and production method therefor |
| 07/17/2002 | EP1222916A2 Use of amino-alcohol derivatives containing a urea function as moisturiser in cosmetic or dermatological compositions |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1222033A1 Pore structures for reduced pressure aerosolization |
| 07/17/2002 | EP1221974A2 Magnetic targeted carrier |
| 07/17/2002 | EP1221971A2 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 07/17/2002 | EP1221959A2 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 07/17/2002 | EP1221957A2 Method for preparing a composition by mother-of-pearl extraction,and use thereof in cosmetics and dermatology |
| 07/17/2002 | EP1221955A2 Immunostimulatory nucleic acids |
| 07/17/2002 | EP1221949A2 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 07/17/2002 | EP1221947A2 Soft gel capsule resistant to gastric juices |
| 07/17/2002 | EP1221945A1 Methods, pharmaceutical and therapeutic compositions for administering adenosine |
| 07/17/2002 | EP1221944A1 Oral dosage form comprising a salt of morphine or a morphine derivative |
| 07/17/2002 | EP1221943A2 Method of producing sub-micron particles of biologically active agents |
| 07/17/2002 | EP1221942A1 Biodegradable microparticles with novel erythropoietin stimulating protein |
| 07/17/2002 | EP1221941A1 Powder pharmaceutical formulations |
| 07/17/2002 | EP1221940A2 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino]benzo g]isoquinoline-5,10-dione dimaleate |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP1221938A2 Method for producing liposome preparation |
| 07/17/2002 | EP1221937A2 Hybrid matrices and hybrid matrix mixtures |
| 07/17/2002 | EP1221927A1 Electrospun skin masks and uses thereof |
| 07/17/2002 | EP1221926A1 Pharmaceutical formulations containing poorly soluble drug substances |
| 07/17/2002 | EP1221919A1 Ophthalmic drug delivery device |
| 07/17/2002 | EP1221917A1 Drug delivery device |
| 07/17/2002 | EP1221908A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/17/2002 | EP1221907A1 Medication retention assembly for oral delivery tray |
| 07/17/2002 | EP1221865A2 Food supplement for increasing lean mass and strength |
| 07/17/2002 | EP1221863A1 Chewing gum containing medicament active agents |
| 07/17/2002 | EP1221841A1 Encapsulated active material immobilized in hydrogel microbeads |
| 07/17/2002 | EP1221840A1 Active material within hydrogel microbeads |
| 07/17/2002 | EP1152709A4 Controlled release composite |
| 07/17/2002 | EP1123104A4 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 07/17/2002 | EP1100474B1 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 07/17/2002 | EP1083900B1 Use of of oxazolidinones for the preparation of a medicament for transdermal delivery |
| 07/17/2002 | EP1044035A4 Methods, systems, and kits for intravascular nucleic acid delivery |
| 07/17/2002 | EP1023034B1 Cosmetic formulations for the prevention and therapy of hair loss |
| 07/17/2002 | EP1017392B1 Medicament formulation with a controlled release of an active agent |
| 07/17/2002 | EP1007086B1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/17/2002 | EP0979224B1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 07/17/2002 | EP0978281B1 Eyedrops containing a loratidine metabolite |
| 07/17/2002 | EP0969860B1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 07/17/2002 | EP0934082B1 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 07/17/2002 | EP0906113B1 Process for preparing a storable preparation consisting of fresh plants, and fresh plant preparation |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0866709A4 1,2,4-benzotriazine oxides formulations |
| 07/17/2002 | EP0861089B1 Methods and compositions for the delivery of monomeric proteins |
| 07/17/2002 | EP0842662B1 Percutaneous tape preparation containing fentanyl |
| 07/17/2002 | EP0822810B1 Tamper evident pharmaceutical dosage form |
| 07/17/2002 | EP0809488B1 Solid active agent preparations |
| 07/17/2002 | EP0755246B1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
| 07/17/2002 | EP0735862B1 Method for dry blend compression of medicaments |
| 07/17/2002 | CN1359469A Epitopes formed by non-covalent association of conjugates |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359389A Substantially crystalline form of melagatran |
| 07/17/2002 | CN1359370A Esters of L-carnitine or alkanoyl L-carnitines |
| 07/17/2002 | CN1359303A Pharmaceutical complex |
| 07/17/2002 | CN1359300A Uro-genital condition treatment system |
| 07/17/2002 | CN1359299A Keratinocyte growth factor-2-formulations |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/17/2002 | CN1359295A Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/17/2002 | CN1359293A Pharmaceutical compositions comprising dipeptidy peptidase in inhibitors for the promotion of growth |
| 07/17/2002 | CN1359291A Aminoethanesulfonic acid-containing preparations |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1359262A Therapeutic anti-fungal nail preparation |
| 07/17/2002 | CN1358734A 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 07/17/2002 | CN1358703A Powder shape mannitol and process for preparing same |
| 07/17/2002 | CN1358535A Tumor-eliminaitng ointment and preparation process |
| 07/17/2002 | CN1358527A Pain-stopping ointment for bone |
| 07/17/2002 | CN1358524A Spraying medicine for treating tinea pedis and process for making same |
| 07/17/2002 | CN1358523A Toxic substance removing ointment |
| 07/17/2002 | CN1358499A Animal phisiologicla and biological activity regulation agent composition containing cysteamine and its salt |
| 07/17/2002 | CN1358498A Hermorrhoid medicinal plaster |
| 07/17/2002 | CN1358497A Sperm-killing father and mother network degradable micro emulsion and preparation process |
| 07/17/2002 | CN1358496A Lead free ointment and preparation process |
| 07/17/2002 | CN1358495A Film forming spraying agent |
| 07/17/2002 | CN1358494A Composition for increasing osmosis of local skin reagent |
| 07/17/2002 | CN1087779C Macroencapsulated secretory cells |
| 07/17/2002 | CN1087623C Antipyretic granular formulation containing remulus cinnamoni, ephedra and bupleurum root |
| 07/17/2002 | CN1087617C Hepatitis curing capsule |
| 07/17/2002 | CN1087613C Pharmaceutical preparations having antithrombotic activity and process for preapring same |
| 07/17/2002 | CN1087610C Lentinus edodes polysaccharide injecta and its preparation |
| 07/16/2002 | US6420624 Blood circulation-promoting powdery material, blood circulation-promoting attachment sheet and blood circulation-promoting attachment sheet set |
| 07/16/2002 | US6420473 Acrylic enteric coating compositions |
| 07/16/2002 | US6420468 Pre-polymerization, monomer(s) dissolved in water-miscible aprotic organic solvent forming non-solvent mixture of polymer; prophylactic or curative antibiotics or antiseptic agents |
| 07/16/2002 | US6420436 Imaging contrast media and methods of use |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |